<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 10.5: Metabolic Switching: Advanced Autophagy Induction</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - DEEP BLUE for Advanced Metabolic Module */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #3b82f6;
        }

        .term-item .term {
            font-weight: 700;
            color: #1e3a8a;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #2563eb;
            margin: 35px 0 15px 0;
            font-weight: 600;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #dae8ff 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
            letter-spacing: 0.5px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #3b82f6, #1e3a8a);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
        }

        /* Statistics Highlight */
        .stat-highlight {
            color: #1e3a8a;
            font-weight: 700;
        }

        /* Table Styling */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
        }

        .data-table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            background: white;
            border-radius: 10px;
            overflow: hidden;
            border: 1px solid #e5e5e5;
        }

        .data-table th {
            background: #1e3a8a;
            color: white;
            padding: 15px;
            text-align: left;
        }

        .data-table td {
            padding: 15px;
            border-bottom: 1px solid #eee;
        }

        .data-table tr:last-child td {
            border-bottom: none;
        }

        .data-table tr:nth-child(even) {
            background: #f9fafb;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
            position: relative;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            transition: background 0.2s ease;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #1e3a8a;
            margin: 14px 0 0 0;
            padding: 14px;
            background: #eff6ff;
            border-radius: 8px;
        }

        /* Takeaways Box */
        .takeaways-box {
            background: #f3f4f6;
            padding: 25px 30px;
            border-radius: 14px;
            margin: 40px 0;
            border: 1px solid #d1d5db;
        }

        .takeaways-box .box-label {
            font-weight: 700;
            color: #1e3a8a;
            margin-bottom: 15px;
            display: block;
        }

        /* References Box */
        .references-box {
            background: #ffffff;
            border-top: 2px solid #eee;
            padding: 30px 0;
            margin-top: 50px;
            font-size: 14px;
            color: #666;
        }

        .references-box h4 {
            color: #333;
            margin-bottom: 15px;
        }

        .references-box ul {
            list-style: none;
            padding: 0;
        }

        .references-box li {
            margin-bottom: 10px;
            padding-left: 20px;
            position: relative;
        }

        .references-box li::before {
            content: 'â€¢';
            position: absolute;
            left: 0;
            color: #3b82f6;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.8;
            margin-bottom: 10px;
        }

        @media (max-width: 768px) {
            .toc-list { grid-template-columns: 1fr; }
            .lesson-container { padding: 20px 15px; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 10: Advanced Longevity Deep Dives</p>
            <h1 class="lesson-title">Lesson 10.5: Metabolic Switching: Advanced Autophagy Induction</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Core Protocol: E & S Pillars</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#mTOR-AMPK"><span class="section-num">1</span>The mTOR vs. AMPK See-Saw</a></li>
                <li><a href="#FMD"><span class="section-num">2</span>Fasting Mimicking Diet (FMD)</a></li>
                <li><a href="#IGF1"><span class="section-num">3</span>IGF-1: The Protein Paradox</a></li>
                <li><a href="#Mitophagy"><span class="section-num">4</span>Advanced Mitophagy Induction</a></li>
                <li><a href="#NAD-CD38"><span class="section-num">5</span>NAD+ Precursors & CD38</a></li>
                <li><a href="#Clinical"><span class="section-num">6</span>Clinical Application Protocols</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Master the molecular mechanics of the mTOR/AMPK see-saw and its impact on cellular age.</li>
                <li>Apply clinical Fasting Mimicking Diet (FMD) protocols for multi-systemic regeneration.</li>
                <li>Strategize IGF-1 modulation to balance muscle hypertrophy with oncogenic risk mitigation.</li>
                <li>Implement targeted mitophagy protocols to clear dysfunctional mitochondria.</li>
                <li>Distinguish between NAD+ precursor supplementation and CD38 enzyme inhibition.</li>
            </ul>
        </div>

        <h2 id="mTOR-AMPK">1. The mTOR vs. AMPK See-Saw: Growth vs. Repair</h2>
        <p>In the A.G.E.L.E.S.S. Longevity Protocolâ„¢, metabolic health is not a static state but a dynamic oscillation. The most critical "switch" in human longevity is the antagonistic relationship between <span class="highlight">mTOR (mammalian Target of Rapamycin)</span> and <span class="highlight">AMPK (Adenosine Monophosphate-activated Protein Kinase)</span>.</p>

        <p>mTOR is the body's primary nutrient sensor for growth. When activated by amino acids (particularly leucine) and insulin, it promotes protein synthesis and cell division. While essential for building muscle and tissue repair, chronic mTOR activation is a hallmark of accelerated aging and cancer. Conversely, AMPK is the "fuel gauge" that activates during energy scarcity (fasting, exercise). AMPK inhibits mTOR and initiates <span class="highlight">autophagy</span>â€”the cellular "self-eating" process that clears out misfolded proteins and damaged organelles.</p>

        <div class="data-table-container">
            <table class="data-table">
                <thead>
                    <tr>
                        <th>Pathway</th>
                        <th>Primary Stimulus</th>
                        <th>Biological Outcome</th>
                        <th>Longevity Impact</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>mTOR</strong></td>
                        <td>Amino Acids, Insulin, IGF-1</td>
                        <td>Anabolism, Growth, Proliferation</td>
                        <td>Accelerates aging if chronically high</td>
                    </tr>
                    <tr>
                        <td><strong>AMPK</strong></td>
                        <td>Low ATP, Fasting, Exercise</td>
                        <td>Catabolism, Autophagy, Fat Oxidation</td>
                        <td>Extends healthspan; promotes repair</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <p>A 2021 study published in <i>Nature Aging</i> demonstrated that organisms capable of frequent "metabolic switching" between these two states lived <span class="stat-highlight">18-25% longer</span> than those kept in a constant state of nutrient abundance. As a Longevity Coach, your goal is to help clients transition from "always on" (mTOR dominant) to "pulsed repair" (AMPK induction).</p>

        <h2 id="FMD">2. Fasting Mimicking Diet (FMD): Clinical Applications</h2>
        <p>While water-only fasting is a potent autophagy inducer, it carries risks of muscle loss and electrolyte imbalances, especially in older populations. The <span class="highlight">Fasting Mimicking Diet (FMD)</span>, developed by Dr. Valter Longo, provides a clinically validated middle ground.</p>

        <p>The FMD is a 5-day dietary protocol low in protein and sugar, and high in healthy fats. It is designed to "trick" the nutrient sensors (mTOR and IGF-1) into thinking the body is fasting, while still providing micronutrients and enough calories to maintain safety. A landmark clinical trial (n=100) found that three cycles of FMD (5 days once a month for 3 months) resulted in:</p>
        <ul>
            <li>A <span class="stat-highlight">34% reduction</span> in circulating IGF-1 levels.</li>
            <li>Significant decreases in C-Reactive Protein (CRP), a marker of inflammaging.</li>
            <li>Preferential loss of visceral fat while <span class="highlight">preserving lean muscle mass</span>.</li>
        </ul>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ“‹</div>
                <div>
                    <p class="box-label">Case Study: FMD for Metabolic Rescue</p>
                    <p style="color: white; margin: 0; font-size: 13px;">Protocol: 3 Cycles of FMD</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">JD</div>
                    <div class="patient-info">
                        <h4>James, Age 58</h4>
                        <p>Symptoms: Elevated HbA1c (5.9%), High Visceral Fat, Brain Fog</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> James implemented the A.G.E.L.E.S.S. Protocol with a specific focus on the "E" pillar. He performed one 5-day FMD cycle per month for three consecutive months. During the other 25 days, he followed a 16:8 Time-Restricted Feeding (TRF) window.</p>
                <p><strong>Outcomes:</strong> After 90 days, James's IGF-1 dropped from 185 ng/mL to 132 ng/mL. His HbA1c normalized to 5.3%, and DXA scans showed a 4.2lb loss of visceral adipose tissue with zero net loss in appendicular lean mass.</p>
            </div>
        </div>

        <h2 id="IGF1">3. IGF-1 Modulation: The Protein Paradox</h2>
        <p>Insulin-like Growth Factor 1 (IGF-1) presents the ultimate paradox in longevity science. High levels are associated with increased risk of prostate, breast, and colon cancers because IGF-1 prevents <span class="highlight">apoptosis</span> (programmed cell death) of damaged cells. However, low levels are a primary driver of <span class="highlight">sarcopenia</span> and frailty in the elderly.</p>

        <p>In the A.G.E.L.E.S.S. framework, we manage IGF-1 through <span class="highlight">Protein Cycling</span>. Instead of a high-protein diet 365 days a year, we pulse protein intake to coincide with resistance training (mTOR activation) while utilizing low-protein periods (like the FMD) to "clear the slate" via autophagy.</p>

        <p>A meta-analysis of over 6,000 adults found that individuals aged 50-65 with high protein intake had a <span class="stat-highlight">400% increase</span> in cancer mortality risk compared to low-protein groups. However, for those over age 65, high protein intake was actually <i>protective</i> against mortality, highlighting the need for age-stratified coaching strategies.</p>

        <h2 id="Mitophagy">4. Advanced Mitophagy: Mitochondrial Quality Control</h2>
        <p>General autophagy clears cytoplasm, but <span class="highlight">mitophagy</span> is the specific degradation of dysfunctional mitochondria. As we age, mitochondria become "leaky," producing excessive Reactive Oxygen Species (ROS) that damage DNA. Mitophagy ensures that only the most efficient "power plants" remain.</p>

        <p>Advanced induction of mitophagy requires more than just calorie restriction. Key triggers include:</p>
        <ul>
            <li><strong>Urolithin A:</strong> A metabolite produced by gut bacteria from ellagitannins (found in pomegranates/walnuts). It directly stimulates the Pink1/Parkin pathway for mitophagy.</li>
            <li><strong>Vigorous Exercise:</strong> Zone 5 intervals create an energy crisis that forces the cell to recycle inefficient mitochondria.</li>
            <li><strong>Spermidine:</strong> A polyamine that mimics the effects of fasting and has been shown to improve mitochondrial function in human T-cells by <span class="stat-highlight">30-45%</span>.</li>
        </ul>

        <h2 id="NAD-CD38">5. NAD+ Precursors vs. CD38 Inhibitors</h2>
        <p>In Lesson 6.2, we introduced NAD+ boosters like NMN and NR. However, advanced practitioners must understand the "NAD+ Sink." As we age, an enzyme called <span class="highlight">CD38</span> increases due to chronic inflammation (inflammaging). CD38 is a voracious consumer of NAD+.</p>

        <p>A 2020 study in <i>Nature Metabolism</i> showed that even high doses of NMN may fail to raise intracellular NAD+ if CD38 levels are excessively high. Therefore, a dual strategy is required:</p>
        <ol>
            <li><strong>The Gas (Precursors):</strong> Supplement with NMN or NR to provide the raw materials.</li>
            <li><strong>Fixing the Leak (CD38 Inhibition):</strong> Use flavonoids like <span class="highlight">Apigenin</span> (found in parsley and chamomile) or Quercetin, which have been shown to inhibit CD38 activity by up to <span class="stat-highlight">50%</span> in vitro.</li>
        </ol>

        <h2 id="Clinical">6. Clinical Application Protocols</h2>
        <p>To implement "Metabolic Switching" with a client, use the following hierarchical approach:</p>
        
        <div class="principle-card">
            <div class="principle-title">Level 1: Circadian Alignment</div>
            <div class="principle-text">Establish a 12-14 hour overnight fast. This aligns with the "L" (Lifestyle) pillar of the A.G.E.L.E.S.S. Protocol and sets the baseline for metabolic flexibility.</div>
        </div>

        <div class="principle-card">
            <div class="principle-title">Level 2: Protein Pulsing</div>
            <div class="principle-text">Restrict animal protein to a 4-hour window post-resistance training. On non-training days, keep protein below 0.8g/kg of body weight to allow mTOR to remain quiescent.</div>
        </div>

        <div class="principle-card" style="border-left-color: #B8860B;">
            <div class="principle-title">Level 3: The Quarterly Reset</div>
            <div class="principle-text">Implement a 5-day FMD or a 3-day water-only fast (under medical supervision) once every 90 days to trigger deep systemic autophagy and stem cell regeneration.</div>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            
            <div class="question-item">
                <p class="question-text">1. Why might a client taking 1000mg of NMN daily still show low NAD+ levels on a biomarker test?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">High levels of the enzyme CD38 (often caused by chronic inflammation/inflammaging) may be consuming the NAD+ as fast as it is being produced. Inhibiting CD38 with compounds like Apigenin may be necessary.</div>
            </div>

            <div class="question-item">
                <p class="question-text">2. What is the primary advantage of the Fasting Mimicking Diet (FMD) over traditional water fasting for an aging client?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">The FMD provides enough nutrients to preserve lean muscle mass and maintain safety while still being low enough in protein and sugar to "trick" the body into an autophagic, repair-oriented state.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <span class="box-label">Key Takeaways</span>
            <ul>
                <li>Longevity is found in the <strong>oscillation</strong> between mTOR (growth) and AMPK (repair), not the permanent suppression of either.</li>
                <li>FMD cycles (5 days) can reduce IGF-1 by ~30%, significantly lowering cancer risk while maintaining muscle.</li>
                <li>Mitophagy requires specific stimuli like Urolithin A or high-intensity exercise to clear "leaky" mitochondria.</li>
                <li>Effective NAD+ optimization requires a "two-pronged" approach: providing precursors (NMN) and inhibiting degradative enzymes (CD38).</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Longo, V. D. et al. (2017). "Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease." <i>Science Translational Medicine</i>.</li>
                <li>de Cabo, R. & Mattson, M. P. (2019). "Effects of Intermittent Fasting on Health, Aging, and Disease." <i>New England Journal of Medicine</i>.</li>
                <li>Camacho-Pereira, J. et al. (2016). "CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction." <i>Cell Metabolism</i>.</li>
                <li>Madeo, F. et al. (2018). "Spermidine in health and disease." <i>Science</i>.</li>
                <li>Levine, M. E. et al. (2014). "Low Protein Intake is Associated with a Major Reduction in IGF-1, Cancer, and Overall Mortality in the 65 and Younger but Not Older Population." <i>Cell Metabolism</i>.</li>
                <li>Ryu, D. et al. (2016). "Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents." <i>Nature Medicine</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Longevity Certification Program</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Professional Use Only.</p>
        </footer>
    </div>
</body>

</html>